secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001641172-25-006224
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals changes auditor from Marcum to CBIZ CPAs; going concern and material weaknesses cited
--------------------------------------------------------------------------------

- Marcum LLP resigned as independent auditor on April 24, 2025; CBIZ CPAs P.C. appointed on April 25, 2025.
- Audit reports for FYE 2024 and 2023 included a going concern explanatory paragraph due to substantial doubt.
- Material weaknesses in internal controls identified: inadequate segregation of duties, lack of review controls, restatement.
- No accounting disagreements between Company and Marcum; no reportable events except the material weaknesses noted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225006224/0001641172-25-006224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225006224/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-006224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer